ProfileGDS5822 / ILMN_2750321
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 16% 26% 33% 15% 53% 6% 23% 15% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 111.716
GSM1276600PDAC Late Ablation Control 216.426
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 114.133
GSM1276603PDAC Late Ablation 210.415
GSM1276604PDAC Late Ablation 326.253
GSM1303940PDAC Late Ablation_anti-CTLA4 17.96
GSM1303941PDAC Late Ablation_anti-CTLA4 21223
GSM1303942PDAC Late Ablation_anti-CTLA4 38.715